Indian eyewear retailer Lenskart said a surge in eye tests and an aggressive store-opening push helped it more than double net profit in the quarter ended September 30. The company reported net profit of 2.27 billion rupees, up from 1.02 billion rupees a year earlier, while revenue climbed nearly 36% to 28.45 billion rupees.
The results underscore how Lenskart's strategy of using in-store eye exams as a gateway to sales is paying off. Eye tests jumped 44.1% year-on-year, and eyewear unit sales rose 26.5%. In India, revenue grew 35.5% to 16.68 billion rupees, helped by 20.8% same-store sales growth—a measure of sales at locations open for at least a year—and the addition of 143 net new stores.
Why eye tests matter
For Lenskart, eye tests are the top of its retail funnel. When a customer walks in for an eye exam, the company can capture a prescription on the spot, making it far more likely that the customer will buy glasses or contact lenses from Lenskart rather than a competitor. More tests typically mean more prescriptions captured in-house, which can convert into eyewear purchases.
There's also a potential boost to the average transaction value. If customers use their eye-test visit to trade up to higher-priced items like progressive lenses, contact lenses, or sunglasses, the average sale rises. That matters because once a store is open, rent and staff costs are largely fixed. When sales grow faster than those fixed costs, margins improve—and that's exactly what happened this quarter.
International expansion and the road ahead
Lenskart's international business, which generated 12.01 billion rupees in revenue, grew 36.5% year-on-year. But investors will want to know how much of that growth came from underlying demand versus currency tailwinds. A weaker rupee, for example, can inflate the value of overseas sales when converted back to rupees.
The company's rapid expansion raises the bar for future performance. Adding 143 net new stores in India in a single quarter is a bold bet. Those new locations only pay off if same-store sales remain strong and new stores mature quickly. If the pace of store openings outpaces demand, the company could face margin pressure.
Lenskart's results come amid a broader trend of Indian consumer companies benefiting from rising discretionary spending. For context, Nykaa's profit nearly tripled on premium beauty demand, showing that Indian shoppers are willing to spend on lifestyle categories. Similarly, Zydus Lifesciences saw revenue rise but profit fall on rising costs, highlighting that not all growth translates to the bottom line.
What it means for investors
For everyday investors, Lenskart's quarter is a reminder that retail growth stories often hinge on operational details. Same-store sales growth is a key metric because it shows whether existing stores are becoming more productive, rather than just relying on new openings. Lenskart's 20.8% same-store growth is strong, suggesting that its existing locations are doing well.
The eye-test growth is doing double duty as a profit lever. If eye-test volumes keep pulling customers into stores and converting into purchases, the profit jump could be repeatable. But the flip side is that rapid expansion raises the bar: each new store must generate enough sales to cover its costs and contribute to profit.
Investors will also watch how Lenskart manages its international business. Currency fluctuations can distort growth figures, so it's important to look at underlying demand. The company's ability to sustain growth outside India will be a key factor in its long-term valuation.
As with any high-growth retailer, the risk is that expansion outpaces demand. But for now, Lenskart's numbers suggest that its strategy of using eye tests to drive sales is working. The company's profit jump is a clear sign that its model is gaining traction, and investors will be watching to see if it can keep the momentum going.
